Prospective Evaluation of PRP and BMC Treatment to Accelerate Healing After ACL Reconstruction

Condition:   Osteoarthritis, Knee Interventions:   Biological: Leukocyte-Poor Platelet Rich Plasma (LP-PRP);   Biological: Bone Marrow Concentrate (BMC);   Other: Control group (Placebo) Sponsors:   Steadman Philippon Research Institute;   United States Department of Defense;   Office of Naval Research (ONR) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials